リポソームドキソルビシンの世界市場2022年-2030年

• 英文タイトル：Liposomal Doxorubicin Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030

• レポートコード：SRT22JL0003 • 出版社/出版日：Straits Research / 2022年5月 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：化学

• 販売価格（消費税別）

Single User	￥570,000 (USD3,800)	▷ お問い合わせ
Department License	￥720,000 (USD4,800)	▷ お問い合わせ
Corporate/Global Licence	￥870,000 (USD5,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Straits Researchの当調査資料は、世界のリポソームドキソルビシン市場を調査対象とし、市場概要、主要企業、種類別分析、用途別分析、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの多面的な分析結果をまとめております。当書に掲載されている企業情報には、Zydus Cadila、Johnson & Johnson、CSPC、Teva、Kinyond、Sun Pharmaceutical、Fudan-Zhangjiang、TTY Biopharmaなどが含まれています。 ・市場概要 ・主要企業 ・世界のリポソームドキソルビシン市場規模：種類別 ・世界のリポソームドキソルビシン市場規模：用途別 ・アジア太平洋のリポソームドキソルビシン市場規模 ・ヨーロッパのリポソームドキソルビシン市場規模 ・北米のリポソームドキソルビシン市場規模 ・南米のリポソームドキソルビシン市場規模 ・中東・アフリカのリポソームドキソルビシン市場規模

Summary:
In this Liposomal Doxorubicin Market report, offers a comprehensive analysis of key market trends in the global Liposomal Doxorubicin market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. The report extensively provides quantitative analysis of the industry from 2022-2030, by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The global liposomal doxorubicin market size was valued at USD 814.7 million in 2015 and is projected to grow at a CAGR of 7.2% during the forecast period.

Geographically, global Liposomal Doxorubicin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Zydus Cadila
Johnson & Johnson
CSPC
Teva
Kinyond
Sun Pharmaceutical
Fudan-Zhangjiang
TTY Biopharma

Production, consumption, revenue, market share and growth rate are the key targets for Liposomal Doxorubicin from 2022 to 2030 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Reasons for Doing the Study:
This report is an update of an earlier (2022) Research study. Since the previous edition of this report was published, the Liposomal Doxorubicin market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.

If you have any special requirements, please let us know and we will offer you the report as you want.

レポート目次

---

Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Liposomal Doxorubicin
Figure Global Liposomal Doxorubicin Market Share by Type in 2021
1.4 By Application
Table Application of Liposomal Doxorubicin
Figure Global Liposomal Doxorubicin Market Share by Application in 2021
1.5 By Region
Figure Global Liposomal Doxorubicin Market Share by Region in 2021
Figure Asia Liposomal Doxorubicin Market Share by Region in 2021
Part 2 Key Companies
2.1. Company Profile
Table Overview List
2.2 Products & Services Overview
2.3 Sales Data List
Table Liposomal Doxorubicin Business Operation of (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Liposomal Doxorubicin Market by Region, 2019-2020 (Million USD)
Figure Global Liposomal Doxorubicin Market Share by Region in 2021 (Million USD)
Table Global Liposomal Doxorubicin Market by Region, 2019-2020 (Volume)
Figure Global Liposomal Doxorubicin Market Share by Region in 2021 (Volume)
Table Price List by Region, 2019-2020
3.2 Global Market by Company
Table Global Liposomal Doxorubicin Market by Company, 2019-2020 (Million USD)
Figure Global Liposomal Doxorubicin Market Share by Company in 2021 (Million USD)
Table Global Liposomal Doxorubicin Market by Company, 2019-2020 (Volume)
Figure Global Liposomal Doxorubicin Market Share by Company in 2021 (Volume)
Table Price List by Company, 2019-2020
3.3 Global Market by Type
Table Global Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure Global Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table Global Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure Global Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
3.4 Global Market by Application
Table Global Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure Global Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table Global Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure Global Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
3.5 Global Market by Forecast
Figure Global Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Global Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure Asia-Pacific Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure Asia-Pacific Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure Asia-Pacific Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure Asia-Pacific Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure China Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure China Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure China Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Southeast Asia Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Southeast Asia Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Southeast Asia Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure India Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure India Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure India Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Japan Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Japan Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Japan Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Korea Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Korea Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Korea Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Oceania Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Oceania Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Oceania Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Asia-Pacific Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure Europe Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table Europe Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure Europe Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
5.2 Europe Market by Application
Table Europe Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure Europe Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table Europe Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure Europe Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Germany Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Germany Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Germany Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure UK Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure UK Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure UK Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure France Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure France Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure France Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Italy Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Italy Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Italy Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Russia Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Russia Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Russia Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Spain Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Spain Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Spain Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Netherlands Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Netherlands Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Netherlands Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Turkey Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Turkey Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Turkey Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Switzerland Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Switzerland Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Switzerland Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
5.4 Europe Market by Forecast
Figure Europe Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Europe Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure North America Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table North America Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure North America Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
6.2 North America Market by Application
Table North America Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure North America Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table North America Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure North America Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure United States Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure United States Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure United States Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Canada Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Canada Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Canada Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Mexico Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Mexico Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Mexico Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
6.4 North America Market by Forecast
Figure North America Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure North America Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure South America Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table South America Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure South America Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
7.2 South America Market by Application
Table South America Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure South America Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table South America Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure South America Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Brazil Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Brazil Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Brazil Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Argentina Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Argentina Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Argentina Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Columbia Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Columbia Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Columbia Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Chile Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Chile Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Chile Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Liposomal Doxorubicin Market Market Status, 2019-2020 (Million USD)
Figure Peru Liposomal Doxorubicin Market Market Status, 2019-2020 (Volume)
Figure Peru Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure Peru Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
7.4 South America Market by Forecast
Figure South America Liposomal Doxorubicin Market Forecast, 2022-2030 (Million USD)
Figure South America Liposomal Doxorubicin Market Forecast, 2022-2030 (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Liposomal Doxorubicin Market by Type, 2019-2020 (Million USD)
Figure Middle East & Africa Liposomal Doxorubicin Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Liposomal Doxorubicin Market by Type, 2019-2020 (Volume)
Figure Middle East & Africa Liposomal Doxorubicin Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Liposomal Doxorubicin Market by Application, 2019-2020 (Million USD)
Figure Middle East & Africa Liposomal Doxorubicin Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Liposomal Doxorubicin Market by Application, 2019-2020 (Volume)
Figure Middle East & Africa Liposomal Doxorubicin Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
8.3 Middle East & Africa Market by Geography

---